目次

Table of Contents
Description
Search Inside Report
Related Reports

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.3 Market Scope
1.3.1 Market Segmentation
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Stakeholders
1.5 Summary Of Changes

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Key Data From Primary Sources
2.1.2.4 Breakdown Of Primary Interviews
2.2 Market Size Estimation
2.2.1 Bottom-up Approach
2.2.1.1 Approach 1: Company Revenue Estimation Approach
2.2.1.2 Approach 2: Presentations Of Companies And Primary Interviews
2.2.1.3 Growth Forecast
2.2.1.4 Cagr Projections
2.2.2 Top-down Approach
2.3 Market Breakdown & Data Triangulation
2.4 Market Share Assumptions
2.5 Study Assumptions
2.6 Research Limitations
2.7 Risk Assessment

3 Executive Summary

4 Premium Insights
4.1 Hiv Diagnostics Market Overview
4.2 Geographic Growth Opportunities

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Prevalence Of Hiv/Aids
5.2.1.2 Increasing Number Of Blood Transfusions & Blood Donations
5.2.1.3 Advantages Offered By Poc Diagnostic Kits & Instruments
5.2.1.4 Increasing Initiatives For Hiv Awareness Campaigns
5.2.2 Restraints
5.2.2.1 High Cost Of Nats
5.2.3 Opportunities
5.2.3.1 High Growth Potential Of Emerging Economies
5.2.3.2 Trend Of Self-testing And Growing Preference For At- Home Diagnostic Kits
5.2.4 Challenges
5.2.4.1 Operational Barriers And Shortage Of Skilled Laboratory Technicians
5.3 Trends/Disruptions Impacting Customers’ Businesses
5.4 Pricing Analysis
5.4.1 Average Selling Price Of Hiv Diagnostic Products,
By Key Player, 2023
5.4.2 Average Selling Price Trend, By Test Type, 2021−2023
5.4.3 Average Selling Price Trend Of Hiv Diagnostic Instruments,
By Region, 2021−2023 (Usd)
5.5 Value Chain Analysis
5.6 Supply Chain Analysis
5.7 Ecosystem Analysis
5.8 Technology Analysis
5.8.1 Key Technologies
5.8.1.1 Elisa
5.8.2 Complementary Technologies
5.8.2.1 Western Blot Tests
5.8.3 Adjacent Technologies
5.8.3.1 Pcr
5.9 Investment & Funding Scenario
5.10 Patent Analysis
5.11 Trade Analysis
5.11.1 Import Data For Hs Code 3822
5.11.2 Export Data For Hs Code 3822
5.12 Key Conferences & Events, 2025-2026
5.13 Case Study Analysis
5.13.1 Role Of Community-based Organizations (Cbos) In Supporting People With Hiv
5.13.2 Managing High Blood Pressure And Blood Sugar In Hiv-positive Patients
5.14 Regulatory Landscape
5.14.1 Regulatory Bodies, Government Agencies, And Other Organizations
5.14.2 Regulatory Framework
5.14.2.1 North America
5.14.2.1.1 Us
5.14.2.1.2 Canada
5.14.2.2 Europe
5.14.2.3 Asia Pacific
5.14.2.3.1 China
5.14.2.3.2 Japan
5.14.2.3.3 India
5.14.2.4 Latin America
5.14.2.4.1 Brazil
5.14.2.4.2 Mexico
5.14.2.5 Middle East
5.14.2.6 Africa
5.15 Porter’s Five Forces Analysis
5.15.1 Threat Of New Entrants
5.15.2 Threat Of Substitutes
5.15.3 Bargaining Power Of Buyers
5.15.4 Bargaining Power Of Suppliers
5.15.5 Intensity Of Competitive Rivalry
5.16 Key Stakeholders & Buying Criteria
5.16.1 Key Stakeholders In Buying Process
5.16.2 Key Buying Criteria, By Product
5.17 Impact Of Ai/Generative Ai On Hiv Diagnostics Market
5.17.1 Market Potential Of Ai In Hiv Diagnostics
5.17.2 Ai Use Cases
5.17.3 Company Implementation Of Ai
5.17.4 Future Of Ai/Generative Ai

6 Hiv Diagnostics Market, By Test Type
6.1 Introduction
6.2 Screening Tests
6.2.1 Rapid Tests
6.2.1.1 Provision Of Quick Test Results And Ability To Diagnose Hiv Antibodies To Fuel Uptake
6.2.2 Elisa
6.2.2.1 Wide Applications Across Infectious Disease Diagnostics To Drive Market
6.2.3 Other Screening Tests
6.3 Confirmatory Tests
6.3.1 Western Blot Tests
6.3.1.1 Gold Standard Testing For Result Validation To Drive Market
6.3.2 Other Confirmatory Tests
6.4 Monitoring Tests
6.4.1 Viral Load Tests
6.4.1.1 Accurate Provision Of Quantitative Data On Hiv Infections To Boost Demand
6.4.2 Cd4 Tests
6.4.2.1 Ability To Number Cd4 T Lymphocyte Cells To Support Market Growth
6.5 Other Hiv Diagnostic Tests

7 Hiv Diagnostics Market, By Product
7.1 Introduction
7.1.1 Consumables
7.1.2 Assay Kits & Reagents
7.1.2.1 Recurrent Purchase To Fuel Market
7.1.3 Other Consumables
7.2 Instruments
7.2.1 Rising Technological Advancements To Drive Market
7.3 Software & Services
7.3.1 Increasing Demand For Value-added Services & Automated Software To Support Market Growth

8 Hiv Diagnostics Market, By End User
8.1 Introduction
8.2 Diagnostic Laboratories
8.2.1 High Volume Of Hiv Testing Samples To Propel Market
8.3 Hospitals
8.3.1 Increasing Adoption Of Diagnostic Tools And Favorable Reimbursements To Drive Market
8.4 Blood Banks
8.4.1 Rising Number Of Blood Donations To Boost Demand
8.5 Home Care Settings
8.5.1 Increasing Preference For At-home Testing Kits To Support Market Growth
8.6 Other End Users

9 Hiv Diagnostics Market, By Region
9.1 Introduction
9.2 North America
9.2.1 Macroeconomic Outlook For North America
9.2.2 Us
9.2.2.1 High Healthcare Expenditure To Drive Market
9.2.3 Canada
9.2.3.1 Increasing Number Of Hiv Infections And Blood Donations To Drive Market
9.3 Europe
9.3.1 Macroeconomic Outlook For Europe
9.3.2 Germany
9.3.2.1 Favorable Government Healthcare Policies And Reimbursements For Hiv Testing To Drive Market
9.3.3 Uk
9.3.3.1 Rising Government Support For Hiv Awareness Campaigns To Support Market Growth
9.3.4 France
9.3.4.1 High Prevalence Of Hiv/Aids To Boost Demand
9.3.5 Italy
9.3.5.1 Increasing Number Of Blood Donors To Support Market Growth
9.3.6 Spain
9.3.6.1 Rising Adoption Of Nat Technology To Propel Market
9.3.7 Rest Of Europe
9.4 Asia Pacific
9.4.1 Macroeconomic Outlook For Asia Pacific
9.4.2 China
9.4.2.1 Rising Incidence Of Infectious Diseases & Hiv To Propel Market
9.4.3 Japan
9.4.3.1 Growing Adoption Of Advanced Hiv Screening Technologies To Drive Market
9.4.4 India
9.4.4.1 Government Initiatives Such As Free Hiv Testing To Drive Market
9.4.5 Rest Of Asia Pacific
9.5 Latin America
9.5.1 Macroeconomic Outlook For Latin America
9.5.2 Brazil
9.5.2.1 Increasing Uptake Of Technologically Advanced Blood Screening Tests To Drive Market
9.5.3 Mexico
9.5.3.1 Rising Establishment Of Blood Banks To Support Market Growth
9.5.4 Rest Of Latin America
9.6 Middle East & Africa
9.6.1 Rising Number Of Hiv Diagnostics And Surgical Procedures To Fuel Market
9.6.2 Macroeconomic Outlook For Middle East & Africa
9.7 Gcc Countries
9.7.1 Rising Focus On Hiv Testing And Improvements In Healthcare Infrastructure To Support Market Growth
9.7.2 Macroeconomic Outlook For Gcc Countries

10 Competitive Landscape
10.1 Overview
10.2 Key Player Strategies/Right To Win
10.2.1 Overview Of Strategies Adopted By Key Players In
Hiv Diagnostics Market
10.3 Revenue Analysis, 2021-2023
10.4 Market Share Analysis, 2023
10.4.1 Ranking Of Key Market Players
10.5 Company Evaluation Matrix: Key Players, 2023
10.5.1 Stars
10.5.2 Emerging Leaders
10.5.3 Pervasive Players
10.5.4 Participants
10.5.5 Company Footprint: Key Players, 2023
10.5.5.1 Company Footprint
10.5.5.2 Region Footprint
10.5.5.3 Product Footprint
10.5.5.4 End-user Footprint
10.6 Company Evaluation Matrix: Startups/Smes, 2023
10.6.1 Progressive Companies
10.6.2 Responsive Companies
10.6.3 Dynamic Companies
10.6.4 Starting Blocks
10.6.5 Competitive Benchmarking: Startups/Smes, 2023
10.6.5.1 Detailed List Of Key Startups/Sme Players
10.6.5.2 Competitive Benchmarking Of Key Startups/Smes
10.7 Company Valuation & Financial Metrics
10.8 Brand/Product Comparison
10.9 Competitive Scenario
10.9.1 Product/Service Launches & Approvals
10.9.2 Product Launches & Approvals
10.9.3 Deals
10.9.4 Expansions
10.9.5 Other Developments

11 Company Profiles
11.1 Key Players
11.1.1 Abbott
11.1.1.1 Business Overview
11.1.1.2 Products/Services Offered
11.1.1.3 Recent Developments
11.1.1.3.1 Deals
11.1.1.4 Mnm View
11.1.1.4.1 Key Strengths
11.1.1.4.2 Strategic Choices
11.1.1.4.3 Weaknesses & Competitive Threats
11.1.2 Siemens Healthineers
11.1.2.1 Business Overview
11.1.2.2 Products/Services Offered
11.1.2.3 Recent Developments
11.1.2.3.1 Product/Service Launches & Approvals
11.1.2.3.2 Deals
11.1.2.3.3 Other Developments
11.1.2.4 Mnm View
11.1.2.4.1 Key Strengths
11.1.2.4.2 Strategic Choices
11.1.2.4.3 Weaknesses & Competitive Threats
11.1.3 Grifols, S.A.
11.1.3.1 Business Overview
11.1.3.2 Products/Services Offered
11.1.3.3 Recent Developments
11.1.3.3.1 Deals
11.1.3.4 Mnm View
11.1.3.4.1 Key Strengths
11.1.3.4.2 Strategic Choices
11.1.3.4.3 Weaknesses & Competitive Threats
11.1.4 Danaher Corporation
11.1.4.1 Business Overview
11.1.4.2 Products/Services Offered
11.1.4.3 Recent Developments
11.1.4.3.1 Product Launches & Approvals
11.1.4.3.2 Deals
11.1.4.3.3 Expansions
11.1.4.4 Mnm View
11.1.4.4.1 Key Strengths
11.1.4.4.2 Strategic Choices
11.1.4.4.3 Weaknesses & Competitive Threats
11.1.5 Thermo Fisher Scientific Inc.
11.1.5.1 Business Overview
11.1.5.2 Products/Services Offered
11.1.5.3 Recent Developments
11.1.5.3.1 Product/Service Launches & Approvals
11.1.5.3.2 Deals
11.1.5.4 Mnm View
11.1.5.4.1 Key Strengths
11.1.5.4.2 Strategic Choices
11.1.5.4.3 Weaknesses & Competitive Threats
11.1.6 Bio-rad Laboratories, Inc.
11.1.6.1 Business Overview
11.1.6.2 Products/Services Offered
11.1.6.2.1 Deals
11.1.7 F. Hoffmann-la Roche Ltd.
11.1.7.1 Business Overview
11.1.7.2 Products/Services Offered
11.1.7.3 Recent Developments
11.1.7.3.1 Product Launches & Approvals
11.1.7.3.2 Deals
11.1.7.3.3 Expansions
11.2 Other Players
11.2.1 Biomérieux
11.2.2 Hologic, Inc.
11.2.3 Qiagen
11.2.4 Bd
11.2.5 Trinity Biotech
11.2.6 Orasure Technologies, Inc.
11.2.7 Biosynex Sa
11.2.8 Wondfo
11.2.9 Getein Biotech, Inc.
11.2.10 Meril Life Sciences Pvt. Ltd.
11.2.11 Accubiotech Co., Ltd.
11.2.12 Biolytical Laboratories Inc.
11.2.13 Bio Lab Diagnostics (I) Private Limited
11.2.14 Alpine Biomedicals Pvt Ltd.
11.2.15 Molbio Diagnostics Pvt. Ltd.
11.2.16 Fortress Diagnostics
11.2.17 Advacare Pharma (Accuquik)
11.2.18 Adaltis S.R.L.

12 Appendix
12.1 Discussion Guide
12.2 Knowledgestore: Marketsandmarkets’ Subscription Portal
12.3 Customization Options
12.4 Related Reports
12.5 Author Details